YM Stock Falls On Unusually High Volume (YMI)

NEW YORK ( TheStreet) -- YM Biosciences (AMEX: YMI) is trading at unusually high volume Friday with 9.7 million shares changing hands. It is currently at 7.5 times its average daily volume and trading down 5 cents (-2.4%) at $2 as of 4:02 p.m. ET.

YM has a market cap of $194.9 million and is part of the health care sector and drugs industry. Shares are up 25% year to date as of the close of trading on Thursday.

YM BioSciences Inc., a drug development company, develops, markets, and commercializes hematology and cancer-related products.

TheStreet Ratings rates YM as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. You can view the full YM Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVDOWN to 95370 or select from multiple alert options.
null

If you liked this article you might like

10 Biotech Stocks With A History Of Beating Earning Expectations

Breaking Up With Gilead Sciences

The Long YM Bio Nightmare Has Ended -- Happily.

Biotech Stock Mailbag: YM Bio, Infinity, Delcath and Galena

The Next Big Thing In Biotech: ASH Meeting